Position in BIIB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$10,054,568
+$4,869,729 QoQ
Shares Held
46,536
+155.7% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#173
of 1,036 holders
Holding Since
Mar 2020
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Derivatives in BIIB
reported options exposure · as of Mar 31, 2020CallValue
$0
CallShares
0
PutValue
$10,124,160
PutShares
32,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PICTON MAHONEY ASSET MANAGEMENT holds $130,004,533 across 10 Drug Manufacturers - General names. BIIB ranks #5 (7.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
33,628 | $40,334,435 | |
| 2 | JNJ |
Johnson & Johnson
|
96,594 | $24,531,978 | |
| 3 | MRK |
Merck & Co., Inc.
|
176,844 | $22,724,454 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
119,118 | $15,049,368 | |
| 5 | BIIB |
Biogen Inc.
This page
|
46,536 | $10,054,568 | |
| 6 | OGN |
Organon & Co.
|
575,000 | $7,785,500 | |
| 7 | ABBV |
AbbVie Inc.
|
25,497 | $6,416,065 | |
| 8 | AZN |
Astrazeneca PLC
|
13,330 | $2,527,634 |
All Filings in BIIB
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,054,568 | 46,536 | Shares | Sole | 2026-08-13 | |
| 2023-06-30 | $5,184,839 | 18,202 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $4,794,071 | 17,243 | Shares | Sole | 2023-05-08 | |
| 2020-03-31 | $10,124,160 | 32,000 | Put | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||